Modern Retina

Jasmine S. Brown and colleagues found that there are gender differences in ophthalmologist communication patterns, and the COVID-19 pandemic impacted these differences. Female physicians sent longer response communications to patients and more responses per patient compared with male physicians. Read more: https://lnkd.in/eet9AwhJ

Australian investigators identified a potential misdiagnosis rate of geographic atrophy (GA) of 1.9%. While this is low, they advised clinicians of the potential for dystrophies that mimic age-related macular degeneration (AMD) and other atrophic macular pathologies to be incorrectly diagnosed. Read more: https://lnkd.in/eC5AVUDX

The FDA has approved an expanded label for fluocinolone acetonide intravitreal implant (ILUVIEN) that includes an indication for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Read more: https://lnkd.in/e-3EnsCB

The treatment landscape for retinal diseases is advancing rapidly, with novel therapies and clinical trials offering new hope for patients with conditions such as neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Among the promising areas of research are innovative approaches targeting pan-vascular endothelial growth factor (VEGF) inhibition. Read more: https://lnkd.in/eBhrgksA

Investigators published a recent case report that described the development of bilateral retinal detachments in a teenager. The patient was an otherwise healthy 19-year-old man who had been referred to the Cole Eye Institute for evaluation of retinal detachments. At presentation, the corrected right and left eye visual acuities (VAs) were, respectively, 20/400 and 20/500. Read more: https://lnkd.in/eijVMv4V

Yu reviewed the benefits and limitations of various electrophysiologic technologies in a diverse group of inflammatory conditions affecting the retina and optic nerve. Read more: https://lnkd.in/eD3GdQWt

Stealth BioTherapeutics Inc. has reached 50 percent of the enrollment target in the global Phase 3 ReNEW study (NCT06373731) of elamipretide as a potential treatment in patients with dry age-related macular degeneration . Read more: https://lnkd.in/eqHjbMuu

Chinese investigators found that renal dysfunction is a risk factor associated with the efficacy of intravitreal conbercept (IVC) injections for treating diabetic macular edema. Read more: https://lnkd.in/e768irJ8

Aleksandra Rachitskaya, MD, and Jordan Graff, MD, FACS, discuss how careful patient selection and management of potential complications—including surgical risks, device-related adverse events, and cost-benefit considerations requiring operating room resources—are crucial factors in successfully implementing the port delivery system in clinical practice. Click here to watch now: https://ow.ly/3AsV50Vf2su #surgical #retinaldiseases

In Collaboration with Snowmass Retina & Eye Time is running out to secure your spot at Snowmass Retina & Eye 2025! From March 24–28, join leading experts in Snowmass, Colorado, for transformative insights into retina, glaucoma, and beyond. Earn CME credits, gain actionable knowledge, and connect with peers in one of the most stunning settings. Don’t let this opportunity slip by—register now before it’s too late! https://lnkd.in/eBGuACiS